Hesperetin ameliorates glioblastoma by inhibiting proliferation, inducing apoptosis, and suppressing metastasis

BACKGROUND: Glioblastoma is the most common type of malignant tumor of the brain. Despite substantial improvements in therapy, the 5-year survival rate of patients with glioblastoma remains low. Antitumor drug development has encountered considerable obstacles, which can be attributed to metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qian, Mao, Lianzhi, Huang, Hongxiang, Tang, Longguang, Jiang, Hongyan, Zhang, Yufei, Mu, Qingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273669/
https://www.ncbi.nlm.nih.gov/pubmed/35836521
http://dx.doi.org/10.21037/tcr-22-1497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273669/
https://www.ncbi.nlm.nih.gov/pubmed/35836521
http://dx.doi.org/10.21037/tcr-22-1497

Ejemplares similares